Log in to save to my catalogue

High-throughput approaches for precision medicine in high-grade serous ovarian cancer

High-throughput approaches for precision medicine in high-grade serous ovarian cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a121541ced524af7b018c4f24ed265be

High-throughput approaches for precision medicine in high-grade serous ovarian cancer

About this item

Full title

High-throughput approaches for precision medicine in high-grade serous ovarian cancer

Publisher

England: BioMed Central Ltd

Journal title

Journal of hematology and oncology, 2020-10, Vol.13 (1), p.134-134, Article 134

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

High-grade serous carcinoma (HGSC) is the most prevalent and aggressive subtype of ovarian cancer. The large degree of clinical heterogeneity within HGSC has justified deviations from the traditional one-size-fits-all clinical management approach. However, the majority of HGSC patients still relapse with chemo-resistant cancer and eventually succum...

Alternative Titles

Full title

High-throughput approaches for precision medicine in high-grade serous ovarian cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a121541ced524af7b018c4f24ed265be

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a121541ced524af7b018c4f24ed265be

Other Identifiers

ISSN

1756-8722

E-ISSN

1756-8722

DOI

10.1186/s13045-020-00971-6

How to access this item